Over the past two decades, the landscape of medical cannabis in the United States has shifted dramatically. Once stigmatized and dismissed as a dangerous substance, cannabis is now recognized as a legitimate treatment option for a wide range of conditions. Alongside expanding legalization and a growing body of research, powerful personal stories of healing continue… Read more

The rapid acceptance and legalization of cannabis across the United States have ignited growing interest in its biological effects—particularly its interaction with the endocannabinoid system (ECS). This intricate network of receptors, enzymes, and naturally produced cannabinoids plays a central role in maintaining balance within the human body, influencing mood, pain, immune function, and metabolism. As… Read more

The recent surge in the acceptance and legalization of cannabis in the United States has brought to light its multifaceted benefits, particularly in the realm of wellness. With an increasing number of states legalizing medical and recreational cannabis use, the conversation around its mind-body connection has gained traction. Cannabidiol (CBD) and tetrahydrocannabinol (THC) are at… Read more

London, United Kingdom — A growing body of evidence is pointing toward the therapeutic potential of medical cannabis in the treatment of substance use disorders (SUD), particularly among individuals struggling with opioid dependence. A new observational study published in the peer-reviewed journal European Addiction Research has found that sustained use of cannabis-based medicinal products (CBMPs)… Read more

For decades, cannabis has been locked in a federal legal limbo—classified as a Schedule I drug alongside heroin, deemed to have “no accepted medical use.” But the tide is beginning to turn. In April 2024, the Drug Enforcement Administration (DEA) took initial steps to reclassify marijuana as a Schedule III drug, a category that includes… Read more

The landscape of medical treatment in the United States is evolving rapidly, thanks in large part to major strides in cannabis research. As public attitudes shift and scientific understanding deepens, cannabis is emerging as a powerful tool in modern medicine—offering hope for patients across a wide range of conditions. This article highlights recent breakthroughs in… Read more

More than 10 million people worldwide live with Parkinson’s disease—a progressive neurological disorder that disrupts movement and often brings tremors, stiffness, and balance issues. But emerging research suggests that medical marijuana may offer meaningful relief for many of these individuals. Studies from respected institutions are increasingly pointing to the therapeutic potential of cannabis in managing… Read more

Even as the federal government continues to classify marijuana as a Schedule I substance—defined as having no accepted medical use and a high potential for abuse—multiple U.S. agencies are now quietly contradicting that stance. Most recently, the U.S. Department of Agriculture (USDA) added Cannabis sativa to its plant database with documented “medicinal” uses. The listing… Read more

A coalition of 45 advocacy and medical organizations—including Americans for Safe Access (ASA), the U.S. Pain Foundation, National Multiple Sclerosis Society, Epilepsy Foundation of America, and others—is urging Congress to safeguard state medical cannabis programs in federal spending legislation and to allow federal cannabis rescheduling efforts to proceed. In a letter sent Monday to House… Read more

As more states legalize cannabis for both medical and recreational use, a growing number of Americans living with chronic pain are exploring cannabis as an alternative to traditional pain treatments. This shift is reshaping the landscape of pain management—and sparking new conversations among patients, healthcare providers, and policymakers. Cannabis Use Among Chronic Pain Patients on… Read more